Subscription banner for an ophthalmic newsletter
Glaukos' iDose TR for Glaucoma Hits the Market

Glaukos Corporation's iDose TR, using Celanese's VitalDose EVA (Ethylene Vinyl Acetate), to provide ...

read more
Glaukos' iDose TR for Glaucoma Hits the Market
March 04, 2024
Brolucizumab Shows Promise Over Aflibercept for Diabetic Macular Edema: Insights from a Meta-Analysis

A recent meta-analysis comparing two anti-VEGF therapies—brolucizumab and aflibercept—for the treatm...

read more
Brolucizumab Shows Promise Over Aflibercept for Diabetic Macular Edema: Insights from a Meta-Analysis
December 30, 2024
Inward Turning Eyelids: A Comprehensive Guide to Entropion

. In this article, we will discuss the definition, types, causes, and differences from ectropion....

read more
Inward Turning Eyelids: A Comprehensive Guide to Entropion
May 16, 2023
Understanding Ectopia Lentis: Causes, Symptoms, and Treatment

Ectopia lentis refers to a situation where the lens within the eye shifts from its usual position, i...

read more
Understanding Ectopia Lentis: Causes, Symptoms, and Treatment
August 08, 2023
Roche’s Vabysmo Receives CHMP Recommendation for RVO Indication

Roche announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medic...

read more
Roche’s Vabysmo Receives CHMP Recommendation for RVO Indication
July 02, 2024
Cyclodialysis Procedure with Scleral Reinforcement Effectively Lowers IOP in Open-Angle Glaucoma

A recent study published in Clinical Ophthalmology demonstrated that a bio-interventional cyclodialy...

read more
Cyclodialysis Procedure with Scleral Reinforcement Effectively Lowers IOP in Open-Angle Glaucoma
December 31, 2024
Shedding Light on Optic Neuritis: Causes and Treatments

In this article, we will explore the causes, symptoms, and treatments of optic neuritis....

read more
Shedding Light on Optic Neuritis: Causes and Treatments
May 17, 2023
FDA Approves Clobetasol Propionate Eye Drop for Post-Op Inflammation and Pain

The U.S. Food and Drug Administration (FDA) has approved clobetasol propionate ophthalmic suspension...

read more
FDA Approves Clobetasol Propionate Eye Drop for Post-Op Inflammation and Pain
March 05, 2024
Valo Health Suspends Development of OPL-0401 for Diabetic Retinopathy After Phase 2 Study

Valo Health has announced the results of its Phase 2 SPEC¬TRA study evaluating OPL-0401 in patients ...

read more
Valo Health Suspends Development of OPL-0401 for Diabetic Retinopathy After Phase 2 Study
January 03, 2025
Study Suggests New Treatment Approach for Wet AMD

A recent study conducted on mice has provided promising insights into a potential alternative treatm...

read more
Study Suggests New Treatment Approach for Wet AMD
July 03, 2024
More